- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03763435
The Effects of Pregnancy Classes and Contributing Factors to Postpartum Depression
The Effects of Pregnancy Classes on Postpartum Depression and Contributing Factors to Postpartum Depression
It is recommended by the American College of Obstetricians and Gynecologists' Committee on Obstetric Practice that all obstetricians screen each women for postpartum depression and anxiety with a validated instrument. Although much effort is made, the contributing factors still lack in the literature due to its multi-factorial nature and complexity.
In addition, the effects of prenatal education classes remain understudied. Therefore, this study aims to demonstrate the prevalence, characteristics and contributing factors of the postpartum depression. In addition, the change in prevalence and characteristics of the postpartum depression among women who had prenatal classes and not will also be assessed.
Study Overview
Status
Intervention / Treatment
Detailed Description
Specific and validated instruments will be performed to women in their 8th week of postpartum period.
Those instruments are:
Edinburgh Postpartum Depression Scale (EPDS) Female genital self-image scale (FGSIS) Insomnia Severity Index (ISI) Breast-feeding efficacy scale short form (BSES-SF) Beck Depression Scale
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Bartin, Turkey
- Recruiting
- Bartin State Hospital
-
Contact:
- Murat Yassa, MD
-
Sub-Investigator:
- Nahide YAZICI, Midwife
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All women in the puerpera period (who gave consent)
Exclusion Criteria:
- None.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Antenatal Classes Received
Women who are involved into at least 3 comprehensive session of Antenatal pregnancy classes (educational) during the prenatal period.
|
At least three comprehensive full-day educational program covering all the stages of pregnancy.
|
|
Without education
Groups are not randomized for not to give rise to ethical problems in order to maximize the community health care.
Only women who are not involved into the educational classes due to their inaccessibility related to their own conditions or wishes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postpartum Depression
Time Frame: Change between the 4th, 8th and 12th weeks of postpartum period
|
Postpartum Depression scores will be measured by Edinburgh Postpartum Scale (EDPS).
The EDPS was developed to identify women who may have postpartum depression.
Each answer is given a score of 0 to 3 .
The maximum score is 30.
The EPDS is a 10-item questionnaire.
Women are asked to answer each question in terms of the past seven days.
A score is calculated by adding the individual items as indicated A score of more than 10 suggests minor or major depression may be present.
|
Change between the 4th, 8th and 12th weeks of postpartum period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Genital self-image
Time Frame: At 4th, 8th and 12th week of postpartum period
|
Genital Self-image scores will be measured by Female Genital Self Image Scale (FGSIS). FGSIS measures the genital self-image of the participants. The seven-item FGSIS assesses women's feelings and beliefs about their own genitals using a 4-point response scale (strongly agree, agree, disagree, strongly disagree). Respondents'scores on each item were summed for a total sum score ranging from 7 to 28, with higher scores indicating more positive genital self-image. |
At 4th, 8th and 12th week of postpartum period
|
|
sleep disorders
Time Frame: At 4th, 8th and 12th week of postpartum period
|
Sleep problems will be measured by Insomnia Severity Index (ISI).
The ISI is a 7-item self-report questionnaire assessing the nature, severity, and impact of insomnia.
A 5-point Likert scale is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28.
The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28).
|
At 4th, 8th and 12th week of postpartum period
|
|
breast-feeding
Time Frame: At 4th, 8th and 12th week of postpartum period
|
Breast-feeding will be assessed by the Breastfeeding Self-Efficacy Scale - Short Form (BSES-SF).
It is a 14 item self-report instrument developed to measure a mother's perceived ability to breastfeed her infant.
It has a five-point Likert scale for rating from 1 ("not at all confident") to 5 ("always confident").
Items ratings will be summed to produce a total score from 14 to 70, with higher scores indicating higher confidence.
The means score points will be used as the cut-off point between high and low scorers.
|
At 4th, 8th and 12th week of postpartum period
|
|
socio-economic-demographical features
Time Frame: At 4th postpartum week
|
Social, economic and demographic features will be assessed by a structured non-validated data gathering form
|
At 4th postpartum week
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Bartin2018-3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Disorder
-
Matrouh UniversitySuez Canal University; Beni-Suef University; University of Bisha, Saudia ArabiaCompletedSleep Disorder | Sleep Hygiene | Sleep Disorder; Insomnia Type | Sleep Disorder in Elderly | Sleep Disorder, Mental Health | Sleep Disorders, Physical HealthEgypt
-
University of ManitobaRecruitingSleepwalking | Sleep Terror | Nightmare Disorder | REM Sleep Behavior Disorder (iRBD) | Confusional ArousalCanada
-
University of UtahRecruitingREM Sleep Behavior Disorder | Nightmare | Nightmare Disorder With Associated Other Sleep DisorderUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedSleep Disorder | Diarrhea | Anxiety Disorders | Insomnia | Sleep Initiation and Maintenance Disorders | Anxiety | Sleep Disturbance | Gastrointestinal Dysfunction | Heartburn | Caffeine | Caffeine Withdrawal | Caffeine; Sleep Disorder | Caffeine Dependence | Caffeine-Induced Anxiety Disorder | Caffeine-Induced Sleep... and other conditionsUnited States
-
Johannes Gutenberg University MainzRecruitingSleep Disorder | Restless Legs Syndrome | Insomnia | Sleep Apnea | Narcolepsy | Idiopathic Hypersomnia | Somnambulism | Sleep Disorder Parasomnia | REM Behavior DisorderGermany
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedCircadian Rhythm Sleep Disorder, UnspecifiedUnited States
-
The University of Texas Health Science Center,...Active, not recruitingRapid Eye Movement Sleep Behavior DisorderUnited States
-
Beijing Hospital of Traditional Chinese MedicineNot yet recruitingRapid Eye Movement Sleep Behavior Disorder
-
Institut d'Investigació Biomèdica de BellvitgeIdorsia Pharmaceuticals Ltd.; Hospital Universitari de BellvitgeNot yet recruitingInsomnia | Major Depressive DisorderSpain
-
Uniformed Services University of the Health SciencesUniversity of Minnesota; Walter Reed National Military Medical Center; The Geneva... and other collaboratorsNot yet recruitingPTSD | Insomnia | Nightmare | TBI | REM Behavior Disorder | Sleep Disorder (Disorder)United States
Clinical Trials on Antenatal pregnancy classes
-
Hopital FochCompleted
-
Ordu UniversityNot yet recruitingPregnancy | Fear | Stress (Psychology)Turkey (Türkiye)
-
University of AarhusAarhus University Hospital SkejbyCompletedPregnancy | ParturitionDenmark
-
Riphah International UniversityCompleted
-
University Hospital, GrenobleRegistre de Handicap de l'Enfant et Observatoire Périnatal (RHEOP) Isère,... and other collaboratorsUnknownStillbirth | Infant, Small for Gestational Age | Intrauterine Growth RetardationFrance
-
University of Milano BicoccaCompletedMild Cognitive Impairment | Subjective Cognitive DeclineItaly
-
Centers for Disease Control and PreventionJhpiego; Ministry of Health, TanzaniaTerminatedMalaria | Malaria in PregnancyTanzania
-
Federal University of Rio Grande do SulCompleted
-
St George Hospital, AustraliaThe University of New South Wales; Australian Government Department of Health... and other collaboratorsUnknownOsteoarthritis, Knee | Osteoarthritis, HipAustralia
-
Princess Anna Mazowiecka Hospital, Warsaw, PolandCompleted